Literature DB >> 12571255

Adding a test for human papillomavirus DNA to cervical-cancer screening.

Thomas C Wright1, Mark Schiffman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12571255     DOI： 10.1056/NEJMp020178

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  54 in total

1.  Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples.

Authors:  Maria T Sandri; Paola Lentati; Elvira Benini; Patrizia Dell'Orto; Laura Zorzino; Francesca M Carozzi; Patrick Maisonneuve; Rita Passerini; Michela Salvatici; Chiara Casadio; Sara Boveri; Mario Sideri
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  Human papillomavirus genotyping after denaturation of specimens for Hybrid Capture 2 testing: feasibility study for the HPV persistence and progression cohort.

Authors:  Brandon J LaMere; Janet Kornegay; Barbara Fetterman; Mark Sadorra; Jen Shieh; Philip E Castle
Journal:  J Virol Methods       Date:  2007-07-27       Impact factor: 2.014

Review 3.  Management of low-grade cervical lesions in young women.

Authors:  Susie Lau; Eduardo L Franco
Journal:  CMAJ       Date:  2005-09-27       Impact factor: 8.262

4.  When to test women for human papillomavirus.

Authors:  Mark Schiffman; Philip E Castle
Journal:  BMJ       Date:  2006-01-14

5.  Alterations of T-cell surface markers in older women with persistent human papillomavirus infection.

Authors:  Ana Cecilia Rodríguez; Alfonso J García-Piñeres; Allan Hildesheim; Rolando Herrero; Matthew Trivett; Marcus Williams; Ivannia Atmella; Margarita Ramírez; Maricela Villegas; Mark Schiffman; Robert Burk; Enrique Freer; José Bonilla; Concepción Bratti; Ligia A Pinto
Journal:  Int J Cancer       Date:  2011-02-01       Impact factor: 7.396

6.  Impact of improved classification on the association of human papillomavirus with cervical precancer.

Authors:  Philip E Castle; Mark Schiffman; Cosette M Wheeler; Nicolas Wentzensen; Patti E Gravitt
Journal:  Am J Epidemiol       Date:  2009-12-10       Impact factor: 4.897

7.  Invited commentary: Human papillomavirus infection and risk of cervical precancer--using the right methods to answer the right questions.

Authors:  Eduardo L Franco; Joseph Tota
Journal:  Am J Epidemiol       Date:  2009-12-10       Impact factor: 4.897

8.  Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study.

Authors:  Philip E Castle; Patti E Gravitt; Diane Solomon; Cosette M Wheeler; Mark Schiffman
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

9.  Market survey predictions on the future of US Pap testing.

Authors:  R Marshall Austin; Barbara Benstein; Joel Bentz; Sandra Bigner; Gregory G Freund; Gregory La Rocco; Ibrahim Ramzy; Lynnette Savaloja; Vinod B Shidham
Journal:  Cytojournal       Date:  2009-09-18       Impact factor: 2.091

10.  Genotype distribution of cervical human papillomavirus DNA in women with cervical lesions in Bioko, Equatorial Guinea.

Authors:  Benjamín García-Espinosa; Ma Paz Nieto-Bona; Sonsoles Rueda; Luís Fernando Silva-Sánchez; Ma Concepción Piernas-Morales; Patricia Carro-Campos; Luís Cortés-Lambea; Ernesto Moro-Rodríguez
Journal:  Diagn Pathol       Date:  2009-09-09       Impact factor: 2.644
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.